68 related articles for article (PubMed ID: 33486679)
1. Germline ALK variations are associated with a poor prognosis in glioma and IDH-wildtype glioblastoma.
Bu L; Hameed NUF; Luo C; Hong P; Zhou X; Wang S; Wu S
J Neurooncol; 2021 Mar; 152(1):27-36. PubMed ID: 33486679
[TBL] [Abstract][Full Text] [Related]
2. A machine learning analysis of a "normal-like" IDH-WT diffuse glioma transcriptomic subgroup associated with prolonged survival reveals novel immune and neurotransmitter-related actionable targets.
Nguyen HD; Allaire A; Diamandis P; Bisaillon M; Scott MS; Richer M
BMC Med; 2020 Oct; 18(1):280. PubMed ID: 33059718
[TBL] [Abstract][Full Text] [Related]
3. Pediatric-type high-grade gliomas with PDGFRA amplification in adult patients with Li-Fraumeni syndrome: clinical and molecular characterization of three cases.
Kibe Y; Ohka F; Aoki K; Yamaguchi J; Motomura K; Ito E; Takeuchi K; Nagata Y; Ito S; Mizutani N; Shiba Y; Maeda S; Nishikawa T; Shimizu H; Saito R
Acta Neuropathol Commun; 2024 Apr; 12(1):57. PubMed ID: 38605367
[TBL] [Abstract][Full Text] [Related]
4. Co-expression of cancer driver genes: IDH-wildtype glioblastoma-derived tumorspheres.
Yoon SJ; Son HY; Shim JK; Moon JH; Kim EH; Chang JH; Teo WY; Kim SH; Park SW; Huh YM; Kang SG
J Transl Med; 2020 Dec; 18(1):482. PubMed ID: 33317554
[TBL] [Abstract][Full Text] [Related]
5. Imaging predictors of 4q12 amplified and RB1 mutated glioblastoma IDH-wildtype.
Dono A; Torres J; Nunez L; Arevalo O; Rodriguez-Quinteros JC; Riascos RF; Kamali A; Tandon N; Ballester LY; Esquenazi Y
J Neurooncol; 2024 Mar; 167(1):99-109. PubMed ID: 38351343
[TBL] [Abstract][Full Text] [Related]
6. Whole tumor analysis reveals early origin of the TERT promoter mutation and intercellular heterogeneity in TERT expression.
Appin CL; Hong C; Suwala AK; Hilz S; Mathur R; Solomon DA; Smirnov IV; Stevers NO; Shai A; Wang A; Berger MS; Chang SM; Phillips JJ; Costello JF
Neuro Oncol; 2024 Apr; 26(4):640-652. PubMed ID: 38141254
[TBL] [Abstract][Full Text] [Related]
7. "De novo replication repair deficient glioblastoma, IDH-wildtype" is a distinct glioblastoma subtype in adults that may benefit from immune checkpoint blockade.
Hadad S; Gupta R; Oberheim Bush NA; Taylor JW; Villanueva-Meyer JE; Young JS; Wu J; Ravindranathan A; Zhang Y; Warrier G; McCoy L; Shai A; Pekmezci M; Perry A; Bollen AW; Phillips JJ; Braunstein SE; Raleigh DR; Theodosopoulos P; Aghi MK; Chang EF; Hervey-Jumper SL; Costello JF; de Groot J; Butowski NA; Clarke JL; Chang SM; Berger MS; Molinaro AM; Solomon DA
Acta Neuropathol; 2023 Dec; 147(1):3. PubMed ID: 38079020
[TBL] [Abstract][Full Text] [Related]
8. Using germline variants to estimate glioma and subtype risks.
Eckel-Passow JE; Decker PA; Kosel ML; Kollmeyer TM; Molinaro AM; Rice T; Caron AA; Drucker KL; Praska CE; Pekmezci M; Hansen HM; McCoy LS; Bracci PM; Erickson BJ; Lucchinetti CF; Wiemels JL; Wiencke JK; Bondy ML; Melin B; Burns TC; Giannini C; Lachance DH; Wrensch MR; Jenkins RB
Neuro Oncol; 2019 Mar; 21(4):451-461. PubMed ID: 30624711
[TBL] [Abstract][Full Text] [Related]
9. The role of
Dono A; Ramesh AV; Wang E; Shah M; Tandon N; Ballester LY; Esquenazi Y
Neurooncol Adv; 2021; 3(1):vdab050. PubMed ID: 34131647
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological and molecular landscape of 5-year IDH-wild-type glioblastoma survivors: A multicentric retrospective study.
Miele E; Anghileri E; Calatozzolo C; Lazzarini E; Patrizi S; Ciolfi A; Pedace L; Patanè M; Abballe L; Paterra R; Maddaloni L; Barresi S; Mastronuzzi A; Petruzzi A; Tramacere I; Farinotti M; Gurrieri L; Pirola E; Scarpelli M; Lombardi G; Villani V; Simonelli M; Merli R; Salmaggi A; Tartaglia M; Silvani A; DiMeco F; Calistri D; Lamperti E; Locatelli F; Indraccolo S; Pollo B
Cancer Lett; 2024 Apr; 588():216711. PubMed ID: 38423245
[TBL] [Abstract][Full Text] [Related]
11. Genomic landscape of glioblastoma without IDH somatic mutation in 42 cases: a comprehensive analysis using RNA sequencing data.
Okamoto T; Mizuta R; Takahashi Y; Otani Y; Sasaki E; Horio Y; Kuroda H; Matsushita H; Date I; Hashimoto N; Masago K
J Neurooncol; 2024 May; 167(3):489-499. PubMed ID: 38653957
[TBL] [Abstract][Full Text] [Related]
12. Germline MSH6 Mutation in a Patient With Two Independent Primary Glioblastomas.
Forsström LM; Sumi K; Mäkinen MJ; Oh JE; Herva R; Kleihues P; Ohgaki H; Aaltonen LA
J Neuropathol Exp Neurol; 2017 Oct; 76(10):848-853. PubMed ID: 28922847
[TBL] [Abstract][Full Text] [Related]
13. Serum macrophage-derived chemokine/CCL22 levels are associated with glioma risk, CD4 T cell lymphopenia and survival time.
Zhou M; Bracci PM; McCoy LS; Hsuang G; Wiemels JL; Rice T; Zheng S; Kelsey KT; Wrensch MR; Wiencke JK
Int J Cancer; 2015 Aug; 137(4):826-36. PubMed ID: 25604093
[TBL] [Abstract][Full Text] [Related]
14. Previously reported CCDC26 risk variant and novel germline variants in GALNT13, AR, and MYO10 associated with familial glioma in Finland.
Nurminen R; Afyounian E; Paunu N; Katainen R; Isomäki M; Nurminen A; Scaravilli M; Tolppanen J; Fey V; Kivinen A; Helén P; Välimäki N; Kesseli J; Aaltonen LA; Haapasalo H; Nykter M; Rautajoki KJ
Sci Rep; 2024 May; 14(1):11562. PubMed ID: 38773237
[TBL] [Abstract][Full Text] [Related]
15. Germline cancer predisposition variants and pediatric glioma: a population-based study in California.
Muskens IS; de Smith AJ; Zhang C; Hansen HM; Morimoto L; Metayer C; Ma X; Walsh KM; Wiemels JL
Neuro Oncol; 2020 Jun; 22(6):864-874. PubMed ID: 31970404
[TBL] [Abstract][Full Text] [Related]
16. A Molecular Blueprint to Targeting ALK Gene Fusions in Glioblastoma.
Mack SC; Bertrand KC
Clin Cancer Res; 2023 Jul; 29(14):2567-2569. PubMed ID: 37260294
[TBL] [Abstract][Full Text] [Related]
17. Isocitrate dehydrogenase 1 mutant glioblastomas demonstrate a decreased rate of pseudoprogression: a multi-institutional experience.
Mohammadi H; Shiue K; Grass GD; Verma V; Engellandt K; Daubner D; Schackert G; Gondim MJ; Gondim D; Vortmeyer AO; Kamer AP; Jin W; Robinson TJ; Watson G; Yu HM; Lautenschlaeger T
Neurooncol Pract; 2020 Mar; 7(2):185-195. PubMed ID: 32626587
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology.
Walsh KM; Ohgaki H; Wrensch MR
Handb Clin Neurol; 2016; 134():3-18. PubMed ID: 26948345
[TBL] [Abstract][Full Text] [Related]
19. TSPAN6 could serve as a prognostic biomarker for patients with glioma.
Zeng X; Xie Y; Xie Y; Zhang C
Asian J Surg; 2024 May; 47(5):2250-2252. PubMed ID: 38403542
[No Abstract] [Full Text] [Related]
20. Proteomics of tumor and serum samples from isocitrate dehydrogenase-wildtype glioblastoma patients: is the detoxification of reactive oxygen species associated with shorter survival?
Clavreul A; Guette C; Lasla H; Rousseau A; Blanchet O; Henry C; Boissard A; Cherel M; Jézéquel P; Guillonneau F; Menei P; Lemée JM
Mol Oncol; 2024 May; ():. PubMed ID: 38803161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
